Larynx: Clinical Trials

2 trials for Larynx, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 2

Follow Larynx: new trials by email Literature Review of Larynx trials Research Report on Larynx

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck
Nivolumab, IDO1 Inhibitor BMS-986205, Therapeutic Conventional Surgery - Lip, Oral Cavity Squamous Cell Carcinoma
Phase 2TerminatedThomas Jefferson University652019-04-092026-10-19
Metformin Hydrochloride and Doxycycline in Treating Patients With Head and Neck Squamous Cell Carcinoma
Metformin Hydrochloride, Doxycycline, Metformin +Doxycycline - Larynx, LIP
Phase 2TerminatedSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University72017-04-032026-01-29

Narrower conditions

Laryngeal Diseases (2)  ·  Carcinoma, Squamous Cell (1)  ·  Lymphoid Interstitial Pneumonia (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Broader conditions

Otorhinolaryngologic Diseases (2)  ·  Respiratory Tract Diseases (2)  ·  Carcinoma (1)  ·  Head and Neck Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Neoplasms, Squamous Cell (1)

Interventions

Doxycycline (1)  ·  Metformin (1)  ·  Nivolumab (1)  ·  linrodostat (1)

Sponsors

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)  ·  Thomas Jefferson University (1)

Countries

United States (2)

Top investigators

Adam Luginbuhl, MD (1)  ·  Jennifer Johnson, MD, PhD (1)